Opioid Antagonist class drugs

8 results
  • Contrave

    (naltrexone hydrochloride and bupropion hydrochloride)
    Nalpropion Pharmaceuticals LLC
    Usage: CONTRAVE is indicated for chronic weight management in adults with a BMI of 30 kg/m² or greater (obese) or 27 kg/m² or greater (overweight) with weight-related comorbid conditions, as an adjunct to diet and exercise. Safety with other weight loss products is not established.
  • Lybalvi

    (olanzapine and samidorphan L-malate)
    Alkermes, Inc.
    Usage: LYBALVI is indicated for the treatment of schizophrenia in adults and for Bipolar I disorder in adults, including acute treatment of manic or mixed episodes (as monotherapy or adjunct to lithium/valproate) and maintenance monotherapy.
  • Movantik

    (naloxegol oxalate)
    RedHill Biopharma Ltd
    Usage: MOVANTIK® is indicated for treating opioid-induced constipation (OIC) in adults with chronic non-cancer pain, including those with pain related to prior cancer or its treatment, who do not require frequent opioid dosage increases.
  • Relistor

    (Methylnaltrexone bromide)
    Salix Pharmaceuticals, Inc.
    Usage: RELISTOR is indicated for treating opioid-induced constipation (OIC) in adults with chronic non-cancer pain or advanced illness requiring opioid escalation for palliative care, including those with chronic pain related to prior cancer or its treatment.
  • Suboxone

    (buprenorphine hydrochloride, naloxone hydrochloride)
    INDIVIOR INC.
    Usage: SUBOXONE sublingual film is indicated for the treatment of opioid dependence and should be used as part of a comprehensive treatment plan that includes counseling and psychosocial support.
  • Symproic

    (naldemedine)
    BioDelivery Sciences International Inc
    Usage: SYMPROIC is indicated for treating opioid-induced constipation (OIC) in adults with chronic non-cancer pain, including those with pain related to prior cancer or its treatment, who do not need frequent opioid dosage increases.
  • Vivitrol

    (naltrexone)
    Alkermes, Inc.
    Usage: VIVITROL is indicated for the treatment of alcohol dependence in patients able to abstain before starting therapy and for preventing relapse to opioid dependence following detoxification. It should be used as part of a comprehensive management program that includes psychosocial support.
  • Zubsolv

    (buprenorphine hydrochloride and naloxone hydrochloride)
    Orexo US, Inc.
    Usage: ZUBSOLV is indicated for the treatment of opioid dependence and should be used as part of a comprehensive treatment plan that includes counseling and psychosocial support.